Safety Update: DHE, Triptans, Magnesium, Butterbur & More
You are currently watching a preview of this interview. Unlock the full version by upgrading to an Access Pass bundle! Get FREE access to 8 expert interviews from Day 1 and Day 2 when you register today!
Key Questions
- What is the latest research on the cardiovascular safety of DHE (dihydroergotamine)?
- Why are triptans — one of the top three acute migraine treatments — underutilized?
- What safety concerns impede the use of triptans?
- Why was rofecoxib (Vioxx) pulled from the market? Are there safety concerns for other selective COX-2 inhibitors in migraine management?
- Is magnesium recommended for everyone?
- Is magnesium intake through diet sufficient?
- Are there safety concerns with magnesium supplementation?
- What does the latest research say about the safety of butterbur?
- Can daily use of preventive natural supplements (like feverfew and butterbur) cause dependence or medication overuse headache (MOH)?
Interview Notes
- The End of Migraines: 150 Ways to Stop Your Pain by Dr. Alexander Mauskop
- New York Headache Center
- Why all migraine patients should be treated with magnesium
Treatments Mentioned
- Acetaminophen (paracetamol)
- Aspirin
- Boswellia
- Butterbur (Petadolex)
- Celecoxib (Celebrex)
- Codeine
- Dihydroergotamine (DHE)
- Excedrin
- Feverfew
- Fluoxetine (Prozac)
- Ibuprofen
- Magnesium
- NSAIDs
- OnabotulinumtoxinA (Botox)
- Opioids
- Percocet
- Rofecoxib (Vioxx)
- SSRIs
- Sertraline (Zoloft)
- Sumatriptan (Imitrex)
- Triptans
- Yoga
Please note: The Migraine World Summit’s aim is to bring you a variety of perspectives and expertise, independent of bias or judgment. Alternative theories presented in this video have not been medically reviewed. Views expressed in this interview do not necessarily represent the views of the Migraine World Summit. Please always consult your health care professional and do your own research before making changes to your treatment plan.
Alexander Mauskop, MD
Director
New York Headache Center
Dr. Alexander Mauskop is the director and founder of the New York Headache Center. He is board certified in neurology, with subspecialty certification in headache medicine. Dr. Mauskop is a Fellow of the American Academy of Neurology and the American Headache Society. He is a professor of clinical neurology at SUNY Downstate Health Sciences University. He has published over a hundred articles, abstracts, and reviews, as well as four books. He has delivered more than 500 presentations and lectures in the field of headache over the past 30 years.
Purchase full access to the entire 2024 Summit. Includes:
- All expert interviews with separate audio (MP3) files & transcripts
- Lifetime on-demand access with no annual fee to 2024 Summit
- Interview Summaries
- Treatment Guidelines
- And much more!
Related Talks for: Day 5 (2023)
How to Get Back From Chronic to Episodic Migraine
Stephanie J. Nahas, MD, MSEd, FAHS, FAAN
Could You Have Medication Overuse Headache?
Gisela Terwindt, MD, PhD
Real-World Data on Treatments, Triggers & Weather
Francois Cadiou
The Association of Migraine Disorders (AMD) is devoted to expanding the understanding of migraine disease and its true scope. Migraine is a full body condition with a broad spectrum of symptoms, AMD is focused on including many medical specialties in the management of this disease.
Migraine Buddy is the #1 headache and migraine tracking application. Recommended by the best neurologists in the world, we empower our users to learn and communicate about their condition. Our community of 2.8 million contribute to migraine awareness and research.
One of the best compliments you can give is a 5-star review on Google or a short video sharing how the Summit has helped. You can help others feel confident in the Migraine World Summit. Inspire others to improve their condition through education & self-advocacy.
